Immune dysfunction in chronic lymphocytic leukemia T cells and lenalidomide as an immunomodulatory drug.
Ramsay
Alan G
AG
Gribben
John G
JG
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002908:Chronic Disease; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D000077269:Lenalidomide; D015458:Leukemia, T-Cell / Q000188:drug therapy* / Q000276:immunology*; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D007155:Immunologic Factors; D013792:Thalidomide; D000077269:Lenalidomide